💥Join UPSC 2027,2028 Mentorship (July Batch) + XFactor Notes & Microthemes PDF
Talk to Mentor

Civilsdaily

Login

Subject: Economics

  • Indian Scientists Develop Single Unit Solar Energy Capture and Storage Device

    Why in the News?

    Indian scientists under the Department of Science and Technology (DST) have developed a photo rechargeable supercapacitor that can both capture and store solar energy in a single integrated unit, enabling low cost, self sustaining, and clean energy systems.

    About the Device

    • Known as a Photo Rechargeable Supercapacitor
    • Integrates solar energy harvesting and energy storage
    • Eliminates separate solar panels and batteries
    • Reduces energy loss, cost, and system complexity

    Developed By

    • Researchers at the Centre for Nano and Soft Matter Sciences (CeNS), Bengaluru
    • Developed under the Department of Science and Technology

    Key Technology Used

    • Binder free Nickel Cobalt Oxide (NiCo₂O₄) nanowires
    • Uniformly grown on nickel foam
    • Fabricated using in situ hydrothermal process
    • Forms a porous, conductive three dimensional network
    • Acts as both solar absorber and supercapacitor electrode
    [2014] With reference to technology for solar power production, consider the following statements: 

    1. ‘Photovoltaics’ is a technology that generates electricity by direct conversion of light into electricity, while ‘Solar Thermal’ is a technology that utilizes the Sun’s rays to generate heat which is further used in electricity generation process. 

    2. Photovoltaics generates Alternating Current (AC), while Solar Thermal generates Direct Current (DC). 

    3. India has manufacturing base for Solar Thermal technology, but not for photovoltaics. 

    Which of the statements given above is/are correct? 

    (a) 1 only (b) 2 and 3 only (c) 1, 2 and 3 only (d) None of the above

  • Rs10,000-crore dosage for biobharma

    Why in the News

    India is the 3rd largest pharmaceutical producer by volume and 14th by value, yet remains heavily dependent on imports for high-value biologic medicines. Biologics dominate modern treatment for cancer, diabetes, rheumatoid arthritis, and infectious diseases, while biosimilars offer cost-effective alternatives. The Union Budget 2026-27 announced Biopharma SHAKTI, a ₹10,000-crore initiative over five years to strengthen domestic production of biologics and biosimilars. This is the first dedicated national framework for biopharma, contrasting with earlier schemes that treated biologics as sub-components of biotechnology or pharma policy. The announcement is significant as biologics now account for a major share of therapies for cancer, diabetes, autoimmune disorders, and vaccines, while India aims to capture 5% of the global biopharmaceutical market.

    What Is Biopharma and Why Does It Matter?

    1. Biopharma, or biopharmaceuticals, refers to the part of the pharmaceutical industry that focuses on developing and manufacturing medicines using living biological systems, rather than relying solely on chemical synthesis.
    2. Biopharma medicines are produced by working with cells, microorganisms or other biological materials. These may include human or animal cells, bacteria, fungi or similar biological platforms that are used to grow or produce therapeutic substances
    3. Biopharmaceuticals: Medicines produced using living biological systems such as human or animal cells, bacteria, fungi, or microbes rather than chemical synthesis.
    4. Product categories: Include vaccines, therapeutic proteins, monoclonal antibodies, gene and cell therapies, modern insulin, and recombinant protein drugs.
    5. Biosimilars: Near-identical versions of approved biologic medicines that offer affordable alternatives once patent protection expires
    6. Biologics: They are complex medicines derived from living cells, while biosimilars are highly similar, equally safe, and effective, lower-cost alternatives to already approved biologics.
      1. While biologics are the original, brand-name, and often more expensive drugs, biosimilars are approved after the original patent expires, offering similar, high-quality, and, on average, 15%-35% cheaper, therapeutic options for diseases like cancer and arthritis.

    What is Biopharma SHAKTI?

    1. It is a dedicated national initiative with an outlay of Rs. 10,000 crores over five years, aimed at strengthening India’s end-to-end ecosystem for biologics and biosimilars.
    2. Aim: It is designed to:
      1. support domestic development and manufacturing of high-value biopharmaceutical products and medicines
      2. reduce import dependence
      3. enhance India’s competitiveness in global biologics supply chains.
    3. Institutional expansion: Expansion and strengthening of the Biopharma-focused network through the establishment of three new National Institutes of Pharmaceutical Education and Research (NIPERs) and the upgradation of seven existing NIPERs
    4. Creation of a large-scale clinical research ecosystem, with a proposal to develop over 1,000 accredited clinical trial sites across the country.

    How Is Clinical Research Capacity Being Strengthened?

    1. Trial infrastructure: Proposes 1,000+ accredited clinical trial sites nationwide.
    2. Advanced trials: Enhances capacity for complex biologics and biosimilar trials.
    3. Global credibility: Positions India as a preferred destination for ethical and efficient clinical research.

    What Regulatory Reforms Are Emphasised?

    1. Institutional strengthening: Enhances capacity of the Central Drugs Standard Control Organisation (CDSCO).
    2. Technical expertise: Induction of specialised scientific personnel for biologics evaluation.
    3. Global alignment: Synchronises approval timelines with international regulatory standards.

    What Is the Role of the National Biopharma Mission (NBM)?

    1. Budgetary linkage: Biopharma SHAKTI builds upon the National Biopharma Mission (NBM) launched in 2017.
    2. Mission objective: Transform India into a $100 billion biotech industry and capture 5% global share.
    3. Financial scale: ₹1,500 crore, co-funded by the World Bank.
    4. Implementing agency: Biotechnology Industry Research Assistance Council (BIRAC) under DBT.

    How Do Other Government Schemes Support Biopharma?

    1. BIRAC-led Innovation Support
      1. Infrastructure: 95 bio-incubation centres.
      2. Funding: BIG, SEED, LEAP funds for early-to-commercial stage innovation.
      3. Outcome: Nearly 1,000 innovators supported.
    2. Manufacturing Support Schemes
      1. PLI for Pharmaceuticals: Enhances domestic manufacturing capacity.
      2. Bulk Drug Parks Scheme: Reduces import dependence for APIs.
      3. SPI Scheme: Upgrades MSMEs to WHO-GMP standards.
    3. PRIP Scheme (2023)
      1. Focus: Biosimilars, complex generics, precision medicine, MedTech innovation.
    4. BioE3 Policy and Bio-RIDE Scheme
      1. Objective: Promote biomanufacturing, biofoundries, and bio-AI hubs.
      2. Sectors: Precision biotherapeutics, climate resilience, biobased chemicals.

    Conclusion

    Biopharma SHAKTI represents a consolidation of India’s decade-long investments in biotechnology, innovation, and pharmaceutical manufacturing. By prioritising biologics and biosimilars, the initiative addresses emerging disease patterns, strengthens regulatory credibility, and positions India for higher value capture in the global pharmaceutical economy.

    PYQ Relevance

    [UPSC 2021] What are the research and developmental achievements in applied biotechnology? How will these achievements help to uplift the poorer sections of society?

    Linkage: Biotechnology and applied life sciences are repeatedly tested areas in GS-III, especially in the context of public health, indigenous innovation, manufacturing, and affordability of medicines. Recent UPSC trends show a clear shift from static biotech definitions to policy-driven questions linking science, economy, and governance.

  • Rare Earth Corridors in Coastal States

    Why in the News?

    In Union Budget 2026-27, Finance Minister Nirmala Sitharaman announced the establishment of dedicated Rare Earth Corridors in the coastal states of Odisha, Kerala, Andhra Pradesh and Tamil Nadu to strengthen India’s critical minerals and advanced manufacturing ecosystem.

    What are Rare Earth Corridors?

    • State focused industrial corridors for Mining, Processing, Research andManufacturing of rare earth elements
    • Aim to integrate upstream mining with downstream value addition
    • Anchored in mineral rich coastal regions with Beach Sand Minerals

    Rare Earths in Indian Context

    • Principal source: Beach Sand Minerals (BSM)
    • Key mineral present: Monazite
      • A phosphate mineral
      • Contains Uranium and Thorium
    • Coastal states have rich deposits capable of producing rare earths like Neodymium and Praseodymium

    Link with Rare Earth Magnet Manufacturing Scheme

    • Corridors align with the scheme for Sintered Rare Earth Permanent Magnets
    • Financial outlay: Rs 7,280 crore
    • Target capacity:
      • 6,000 metric tonnes per annum
      • 5 beneficiaries selected via competitive bidding
      • Up to 1,200 MTPA per beneficiary
    • Incentives:
      • Rs 6,450 crore sales linked incentive over 5 years
      • Rs 750 crore capital subsidy

    Why Rare Earth Permanent Magnets Matter

    • Critical for: Electric vehicles, Wind turbines and renewable energy, Electronics and Aerospace and defence.
    • Global concentration: China controls over 90 percent of processing and magnet manufacturing
    • India imported over 53,000 metric tonnes of rare earth magnets in FY 2024-25
    • Domestic demand expected to double by 2030
    [2022] With reference to India, consider the following statements: 1. Monazite is a source of rare earths

    2. Monazite contains thorium

    3. Monazite occurs naturally in the entire Indian coastal sands in India

    4. In India, Government bodies only can process or export monazite

    Which of the statements given above are correct? 

    (a) 1, 2 and 3 only (b) 1, 2 and 4 only (c) 3 and 4 only (d) 1, 2, 3 and 4

  • India gives 20 year tax holiday to foreign firms using local data centres 

    Why in the News?

    In Union Budget 2026–27, Finance Minister Nirmala Sitharaman announced a 20 year tax holiday till 2047 for foreign companies that provide global cloud services using data centres located in India, to boost India’s position as a global data and digital services hub.

    What is the Announcement?

    • Foreign companies offering cloud and digital services globally
    • Using data centres physically located in India
    • Will not be taxed on global income arising from such services
    • Tax holiday applicable till the year 2047

    Key Benefits

    • Provides long term tax clarity and stability
    • Encourages hyperscalers to locate data storage and processing in India
    • Boosts employment, energy infrastructure and allied services
    • Strengthens India’s role in cloud computing, AI and digital trade

    Investments in Focus

    • Google plans 15 billion dollar investment in AI data centres in Andhra Pradesh
    • Microsoft and Amazon have invested billions in Indian data centres
    • Indian conglomerates like Reliance Industries and Adani Group are also major players

    Government View

    • IT Minister Ashwini Vaishnaw stated that data centres will become a major strength for India in providing digital services to the world
    [2018] With reference to India’s decision to levy an equalization tax of 6% on online advertisement services offered by non-resident entities, which of the following statements is/are correct? 1. It is introduced as a part of the Income Tax Act

    2. Non-resident entities that offer advertisement services in India can claim a tax credit in their home country under the “Double Taxation Avoidance Agreements”

    Select the correct answer using the code given below: 

    (a) 1 only (b) 2 only (c) Both 1 and 2 (d) Neither 1 nor 2

  • Biopharma Shakti Mission 

    Why in the News?

    In Union Budget 2026, Finance Minister Nirmala Sitharaman announced the Biopharma Shakti Mission with an outlay of Rs 10,000 crore to make India a global hub for biologics and biosimilars.

    What is Biopharma Shakti Mission?

    A flagship mission to build a complete ecosystem for domestic manufacturing, clinical trials, and regulatory capacity in complex biological drugs.

    Key Features

    • Financial outlay: Rs 10,000 crore over 5 years
    • Focus areas: Biologics and biosimilars for NCDs like diabetes, cancer, autoimmune disorders
    • Infrastructure push:
      • 3 new NIPERs to be set up
      • 7 existing NIPERs to be upgraded
    • Clinical trials:
      • Network of 1,000 accredited clinical trial sites
      • Aims to capture a share of the global clinical trials market
    • Regulatory strengthening:
      • Capacity enhancement of Central Drugs Standard Control Organisation
      • Creation of a dedicated scientific review cadre
      • Alignment with global drug approval timelines

    Significance

    • Supports India’s transition from small molecule generics to next generation biologics
    • Addresses rising non communicable disease burden
    • Improves affordable access to advanced therapies
    • Boosts export competitiveness and global trust in Indian pharma

    Institutions in Focus

    • National Institute of Pharmaceutical Education and Research
    • CDSCO as the national drug regulator aligned to global standards
    [2025] With reference to monoclonal antibodies, consider the following: 1. They are man-made proteins

    2. They stimulate the patient’s immune system to fight the specific disease

    3. They are produced using animal cells only

    Which of the statements given above are correct? 

    (a) I and II only (b) II and III only (c) I and III only (d) All the three

  • [2nd February 2026] The Hindu OpED: Union Budget 2026-27: Pushing welfare towards the States

    PYQ Relevance

    [UPSC 2024] What changes has the Union Government recently introduced in the domain of Centre-State relations? Suggest measures to be adopted to build the trust between the Centre and the States and for strengthening federalism.

    Linkage: The question addresses evolving Centre-State relations, focusing on fiscal federalism, trust deficit, and the balance between autonomy and accountability in India’s federal structure. The article illustrates this shift through the Centre’s reduced welfare spending and increased reliance on States for social-sector delivery without proportional fiscal empowerment.

    Mentor’s Comment

    There is a clear shift in India’s welfare system. Budget 2026-27 shows that States are being made more responsible for welfare spending, while the Union government continues to set rules and standards. It raises concerns about reduced social-sector spending, limited fiscal capacity of States, and unequal governance. The issue is important for GS-II and GS-III as it links fiscal federalism, social justice, public finance, and welfare delivery.

    Why in the News?

    Budget 2026-27 reflects an unusual pattern: despite the absence of new flagship schemes, allocations for core welfare sectors remain low and, in several cases, under-spent. For the first time in recent years, there is a clear shift of welfare burden towards States, while the Centre retains control through legislation and standards. This contrast between decentralised spending responsibility and centralised policy authority marks a significant departure from earlier centrally driven welfare expansion.

    Has social-sector spending lost priority in Budget 2026-27?

    1. Unchanged Social Sector Share: Maintains the same proportion of total expenditure as previous years, despite rising welfare needs.
    2. Health and Education Allocation: Registers a marginal increase of 4% in 2026-27 BE, which translates to only 2.3% growth in real terms after inflation.
    3. Below-Minimum Requirement: Requires at least 7% annual growth to sustain existing service levels, indicating effective stagnation.
    4. Under-Spending Trend: Budget Estimates (BE) consistently exceed Revised Estimates (RE), showing that even allocated funds remain unspent.

    Which welfare schemes are witnessing the sharpest decline?

    1. Urban Livelihoods (DAY-NULM): Allocation reduced by 41%, reflecting declining focus on urban poor employment.
    2. Rural Development: Faces a 20% reduction, weakening livelihood and asset-creation programmes.
    3. North-East Development: Allocation falls by 24%, affecting regional equity.
    4. Social Welfare Programmes: Experience broad-based contraction across sectors.
    5. Jal Jeevan Mission: Allocation drops from ₹67,000 crore in 2025-26 BE to ₹35,000 crore in 2026-27 BE.
    6. PMAY-Urban: Reduced from ₹54,832 crore (RE) to ₹45,482 crore (BE).
    7. PMAY-Rural: Declines from ₹79,794 crore to ₹54,832 crore.
    8. Education Schemes (CSS): Fall from ₹5,41,850 crore in 2025-26 BE to ₹4,20,078 crore in 2026-27 BE.
    9. Health Schemes: Reduced from ₹5,48,798 crore to ₹4,57,498 crore.

    Is the emphasis on capital expenditure displacing welfare priorities?

    1. Capex Bias: Prioritises infrastructure spending over social consumption.
    2. Demand Constraint: Weak purchasing power limits the multiplier effect of capex.
    3. Employment Impact: Fails to generate sufficient jobs, particularly for educated youth.
    4. Private Investment Response: Remains muted, questioning capex-led growth assumptions.
    5. Economic Slackness: Over ₹12 lakh crore remains unspent or underutilised in the economy.

    How is the welfare burden shifting towards the States?

    1. Budget Consolidation: Budget 2026-27 formalises the transfer of welfare responsibility to States.
    2. Centre’s Role: Continues norm-setting through legislation, while reducing direct spending.
    3. Increased State Share: States now bear a larger proportion of social-sector expenditure.
    4. Revenue Constraint: States receive only around 34% of net tax revenues.
    5. Finance Commission Signal: Recommends reduced cesses and surcharges, yet these continue.
    6. Vertical Imbalance: Centre’s tax dominance contrasts with States’ spending obligations.

    Do States have the fiscal capacity to absorb this shift?

    1. Limited Revenue Autonomy: States remain dependent on Central transfers.
    2. Declining Share: States’ share in Central taxes has fallen from ₹1,32,767 crore (2025-26 BE) to ₹1,29,397 crore (2026-27 BE).
    3. Expenditure Pressure: Welfare responsibilities expand without commensurate fiscal space.
    4. Governance Risk: Uneven capacity among States risks regional disparities in welfare outcomes.

    What governance challenges persist in welfare delivery?

    1. Demand-Side Weakness: Poor purchasing power suppresses welfare impact.
    2. Supply-Side Gaps: Inadequate public provisioning persists.
    3. Human Capital Stress: Education and health underinvestment affects long-term productivity.
    4. Structural Unemployment: Skills mismatch remains unresolved.
    5. Income Stagnation: Low wages constrain inclusive growth.

    Conclusion

    As the Centre withdraws from direct welfare spending while retaining legislative authority, States are left managing rising social obligations with constrained fiscal capacity. Without correcting this imbalance, welfare delivery risks becoming uneven, under-funded, and ineffective.

  • What’s ailing India’s battery scheme for EVs

    Why in the News?

    The ₹18,100 crore PLI Scheme for Advanced Chemistry Cell (ACC) Battery Storage, launched to create 50 GWh of domestic battery manufacturing capacity by 2025, has achieved only 1.4 GWh of installed capacity even after multiple bidding rounds. Despite awarding 20 GWh of capacity and disbursing commitments to three beneficiaries, no incentive funds have been released due to missed milestones. The scheme has attracted only 25.58% of the targeted investment, far below expectations. This represents a sharp contrast with the scheme’s original promise of rapidly catalysing India’s EV battery ecosystem and exposes structural weaknesses in mineral supply, technology readiness, and industrial execution.

    What are Advanced Chemistry Cells (ACCs)?

    1. Energy storage systems: Enable storage of electrical energy and conversion back to electricity as required.
    2. Lithium-ion dominance: Represent the most widely used battery chemistry globally, particularly in EVs and electronics.
    3. Technology-agnostic design: Allows multiple chemistries, including lithium manganese cobalt, lithium iron phosphate, and sodium-ion batteries.

    What was the intent behind the ACC PLI scheme?

    1. Manufacturing ecosystem creation: Seeks establishment of large-scale domestic battery manufacturing capacity.
    2. Import substitution: Reduces reliance on Chinese battery imports and supply chains.
    3. Strategic value chain integration: Requires complementary policies for mineral refining and component manufacturing.

    How was the scheme designed to function?

    1. Capacity-linked incentives: Rewards firms based on committed and operational manufacturing capacity.
    2. Minimum scale requirement: Mandates at least 5 GWh per participant to ensure economies of scale.
    3. Investment threshold: Requires ₹225 crore per GWh of committed capacity.
    4. Performance-linked payouts: Allows incentives up to ₹2,000 per kWh sold.
    5. Domestic Value Addition (DVA): Mandates 25% DVA within two years and 60% by the fifth year.

    Who were selected as beneficiaries under the scheme?

    1. Ola Electric: Awarded 20 GWh capacity initially; operationalised only 1.4 GWh by October 2025.
    2. Reliance New Energy: Allocated 5 GWh in the first round and an additional 10 GWh in the second round.
    3. Rajesh Exports: Allocated 5 GWh capacity.

    What has been the actual performance so far?

    1. Capacity shortfall: Only 1.4 GWh operational against a target of 50 GWh by 2025.
    2. Investment gap: Scheme generated only ₹1,118 crore, compared to an expected ₹4,360 crore.
    3. Zero disbursement: No incentive payouts released despite elapsed timelines.
    4. Concentration risk: Entire operational capacity limited to a single beneficiary.

    Why has the ACC PLI scheme underperformed?

    1. Unrealistic gestation period: Two-year commissioning timeline unsuitable for complex battery manufacturing plants.
    2. Mineral processing gaps: India lacks domestic facilities for lithium, nickel, and cobalt refining.
    3. Subsidy-centric design: Emphasises financial incentives without adequate ecosystem readiness.
    4. Execution capability mismatch: New entrants lack manufacturing experience compared to established global players.
    5. Supply chain dependence: Continued reliance on China for raw materials, equipment, and technical approvals.
    6. Regulatory delays: Slow clearance of Chinese technical specialists and technology transfer processes.
    7. Skilled labour deficit: Insufficient trained workforce for precision battery cell manufacturing.

    What does the article recommend going forward?

    1. Faster regulatory approvals: Accelerates visas and clearances for foreign technical expertise.
    2. Penalty relaxation: Extends commissioning deadlines by at least one year to reflect ground realities.
    3. Value chain deepening: Requires targeted schemes for mineral refining and component manufacturing.
    4. Technology and R&D focus: Prioritises domestic innovation over assembly-led expansion.
    5. Human capital development: Builds specialised skill pipelines for battery manufacturing.

    Conclusion

    The ACC PLI scheme reveals that fiscal incentives alone cannot substitute for ecosystem readiness. Manufacturing scale, mineral security, skilled labour, and technological capability must evolve simultaneously. Without structural correction, India’s battery ambitions risk remaining aspirational rather than transformative.

    PYQ Relevance

    [UPSC 2023] The adoption of electric vehicles is rapidly growing worldwide. How do electric vehicles contribute to reducing carbon emissions and what are the key benefits they offer compared to traditional combustion engine vehicles?

    Linkage: Electric vehicles reduce carbon emissions only when supported by clean electricity and efficient energy storage; weak domestic battery manufacturing limits these climate gains. Without strong domestic battery manufacturing, EV adoption may remain limited to vehicle sales rather than real decarbonisation.

  • Union Budget 2026–27 

    Why in the News?

    The Union Budget of India for 2026–27 was presented on 1 February 2026 by Nirmala Sitharaman, focusing on Yuva Shakti, inclusive growth and long term economic resilience.

    Budget Theme and Vision

    • Yuva Shakti driven Budget with focus on poor, underprivileged and disadvantaged
    • First Budget prepared in Kartavya Bhawan
    • Anchored on 3 Kartavya
      • Accelerate and sustain economic growth
      • Fulfil aspirations and build capacity
      • Sabka Sath Sabka Vikas towards Viksit Bharat

    Major Economic and Fiscal Announcements

    • Public Capex increased to ₹12.2 lakh crore in FY 2026–27
    • Fiscal deficit targeted at 4.3 percent of GDP
    • Debt to GDP ratio projected at 55.6 percent
    • Net market borrowing at ₹11.7 lakh crore

    Taxation Reforms

    Direct Taxes

    • New Income Tax Act, 2025 effective from April 2026
    • Simplified income tax rules and forms
    • TCS on overseas tour packages reduced to 2 percent
    • STT on futures increased to 0.05 percent
    • MAT rate reduced to 14 percent and made final tax
    • Multiplicity of penalty and prosecution proceedings reduced

    Support to IT and Global Investment

    • Single category of IT Services with safe harbour margin of 15.5 percent
    • Safe harbour threshold raised to ₹2,000 crore
    • Foreign cloud service providers to get tax holiday till 2047
    • MAT exemption to all non residents paying tax on presumptive basis

    Indirect Taxes and Customs

    • Basic customs duty exemption
      • Capital goods for lithium ion batteries
      • Critical minerals processing equipment
      • 17 drugs and medicines
    • Tariff on personal imports reduced from 20 percent to 10 percent
    • Customs warehousing shifted to operator centric digital system
    • Single digital window for cargo clearance by end of financial year

    Sector Specific Highlights

    Manufacturing and MSMEs

    • ₹10,000 crore SME [Small and Medium Enterprises] Growth Fund
    • Scaling manufacturing in 7 strategic sectors
    • Textile sector integrated programme including Samarth 2.0

    Infrastructure and Transport

    • Seven high speed rail corridors as growth connectors
    • New Dedicated Freight Corridors
    • Operationalisation of 20 National Waterways

    Health, Education and Social Sector

    • Biopharma SHAKTI with outlay of ₹10,000 crore
    • One girls hostel in every district for STEM institutions
    • Medical tourism hubs in partnership with private sector
    • NIMHANS 2 and mental health institutes upgrade

    Technology and AI

    • Bharat VISTAAR multilingual AI tool for agriculture
    • AVGC content creator labs in 15,000 schools and 500 colleges

    Sports and Tourism

    • Launch of Khelo India Mission
    • Upskilling 10,000 tourist guides
    • Buddhist Circuit development in North East
    [2024] With reference to Union Budget, consider the following statements: 

    1. The Union Finance Minister on behalf of the Prime Minister lays the Annual Financial Statement before both the Houses of Parliament

    2. At the Union level, no demand for a grant can be made except on the recommendation of the President of India

    Which of the statements given above is/are correct? 

    (a) 1 only (b) 2 only (c) Both 1 and 2 (d) Neither 1 nor 2

  • New CPI Inflation Series and Changing Consumption Weights

    Why in the News?

    India’s new Consumer Price Index (CPI) series with 2024 as the base year will reduce the weight of food and beverages to about 37 percent from nearly 46 percent, reflecting updated household consumption patterns released by Ministry of Statistics and Programme Implementation.

    What is CPI?

    • CPI measures retail inflation faced by households
    • Used by Reserve Bank of India for monetary policy decisions
    • Forms the basis of inflation targeting at 4 percent within a 2 to 6 percent band

    Key Changes in the New CPI Series

    • Food and beverages weight reduced
      • From 45.86 percent to 36.75 percent
    • Housing weight increased
      • From 10.07 percent to 17.66 percent
    • CPI basket expanded
      • From 299 items to 358 items
    • Based on 2023–24 Household Consumption Expenditure Survey

    Why is Food Weight Being Reduced?

    • Reflects Engel’s Law, which states that as income rises, the share of spending on food falls
    • Rural food share declined from 52.9 percent to 47.04 percent
    • Urban food share declined from 42.62 percent to 39.68 percent
    • Lower food weight is expected to reduce volatility in headline inflation

    Implications for Inflation and RBI

    • High food weight earlier caused sharp swings in CPI due to supply shocks
    • New weights may lead to
      • Slightly higher CPI when food inflation is low
      • Lower CPI when food inflation is high
    • Makes CPI more aligned with current consumption realities
    • Supports smoother monetary policy transmission

    Rising Importance of Housing

    • Housing category expanded to include
      • Water, electricity, gas and other fuels
    • Higher urban spending on rent reflected
    • Methodological changes may lead to higher measured housing inflation
    [2020] Consider the following statements: 1. The weightage of food in Consumer Price Index (CPI) is higher than that in Wholesale Price Index (WPI)

    2. The WPI does not capture changes in the prices of services, which CPI does

    3. Reserve Bank of India has now adopted WPI as its key measure of inflation and to decide on changing the key policy rates

    Which of the statements given above is/are correct? 

    (a) 1 and 2 only (b) 2 only (c) 3 only (d) 1, 2 and 3

  • [31st January 2026] The Hindu OpED: Green steel can shape India’s climate goals tragectory

    PYQ Relevance

    [UPSC 2022] Do you think India will meet 50 percent of its energy needs from renewable energy by 2030? Justify your answer. How will the shift of subsidies from fossil fuels to renewables help achieve the above objective? Explain.

    Linkage: This question is directly relevant to GS Paper 3 (Energy transition, climate change, infrastructure). The article shows that meeting the 50% renewable energy target by 2030 is crucial to decarbonise the steel sector, as large-scale renewable power and green hydrogen are essential to avoid carbon lock-in and achieve India’s revised NDC goals.

    Why in the News?

    India has committed to submitting a more ambitious Nationally Determined Contribution (NDC) before COP30, marking a move from limited climate action to economy-wide decarbonisation. Steel has become a key focus because it accounts for about 12% of India’s total carbon emissions, and steel production is expected to rise from around 125 million tonnes to over 400 million tonnes by mid-century. If action is delayed, current investments could lead to carbon lock-in through coal-based blast furnace technologies, weakening climate targets and reducing export competitiveness as global carbon regulations such as the EU’s Carbon Border Adjustment Mechanism (CBAM) become stricter.

    Why is steel central to India’s climate challenge?

    1. Emissions intensity: Accounts for ~12% of national carbon emissions, largely due to coal-dependent blast furnace routes.
    2. Scale of growth: Projected production increase to 400+ million tonnes risks amplifying emissions without structural change.
    3. Capital lock-in: Steel plants have long life cycles; delayed transition locks emissions for decades.
    4. Economic implications: Carbon-intensive steel risks becoming uncompetitive and unattractive for investment in the medium term.

    What risks arise from delaying the transition to green steel?

    1. High-carbon lock-in: Continued investment in blast furnaces entrenches coal dependence.
    2. Trade vulnerability: Exposure to carbon border taxes under mechanisms such as EU CBAM.
    3. Lost competitiveness: Countries transitioning early gain cost and technology advantages.
    4. Economic damage: Billions locked in carbon-inefficient technologies impose future adjustment costs on industry and the economy.

    What global lessons shape India’s green steel strategy?

    1. International shift: China, Japan, and South Korea are scaling scrap-based secondary steel and hydrogen pathways.
    2. EU regulatory pressure: CBAM compels exporting countries to decarbonise steel production.
    3. Carbon pricing signal: European experience shows near-zero emission steel becomes viable only when carbon prices approach $90-$100 per tonne.
    4. First-mover advantage: Early adopters gain market access, finance, and technology leadership.

    What policy progress has India made so far?

    1. Green Steel Roadmap: Signals a clear long-term decarbonisation pathway for the sector.
    2. Green Steel Taxonomy: Establishes definitions and classification for low-carbon steel.
    3. National Hydrogen Mission: Supports hydrogen-based steelmaking.
    4. PAT expansion: Introduces intensity-based emission targets for 253 steel units.
    5. Carbon Credit Trading Scheme (CCTS): Creates market incentives for emissions reduction.

    What constraints continue to slow the transition?

    1. Hydrogen scarcity: Limited availability of affordable green hydrogen.
    2. Energy bottlenecks: Insufficient renewable power dedicated to industrial use.
    3. Scrap availability: Informal scrap market limits consistent supply.
    4. Technology maturity: Carbon capture and storage (CCS) remains costly and low in maturity.
    5. Financial risk: High capital costs deter private investment without policy certainty.

    What role must the government play going forward?

    1. Regulatory clarity: Establishes firm short-, medium-, and long-term carbon targets.
    2. Carbon pricing: Integrates blast furnaces into carbon pricing at the earliest.
    3. Infrastructure support: Enables shared access to green electricity, hydrogen pipelines, and CO₂ transport networks.
    4. Fiscal support: Provides targeted incentives, especially for smaller producers.
    5. Market creation: Uses public procurement to create demand for green steel.

    Conclusion

    Green steel is no longer optional for India’s climate or economic strategy. It is a strategic imperative linking decarbonisation, industrial competitiveness, and global leadership. By aligning regulation, infrastructure, and finance, India can avoid carbon lock-in, protect export markets, and position itself as a leader in sustainable industrialisation.